Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Based on the Theory of "Body Constitution of Chinese Medicine" and "Combination of Prescription and Syndrome" to Improve COVID-19 Susceptible Body Constitution of Residents in Hong Kong

NCT04668222 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT04668222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04668222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Based on the Theory of "Body Constitution of Chinese Medicine" and "Combination of Prescription and Syndrome" to Improve COVID-19 Susceptible Body Constitution of Residents in Hong Kong
Lead sponsor
The University of Hong Kong
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 30, 2021
Completion date
November 30, 2022
Enrollment
480 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, herbal medicine